California Public Employees Retirement System Eiger Bio Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.82 - $9.23 $437,138 - $515,957	-55,900 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$7.98 - $12.29 $9,576 - $14,747	-1,200 Reduced 2.1%	55,900 $687,000
Q3 2020 Nov 05, 2020	BUY	$7.96 - $12.42 $40,412 - $63,056	5,077 Added 9.76%	57,100 $465,000
Q2 2020 Aug 12, 2020	SELL	$5.4 - $13.37 $540 - $1,337	-100 Reduced 0.19%	52,023 $499,000
Q1 2020 May 12, 2020	BUY	$4.91 - $14.7 $41,244 - $123,480	8,400 Added 19.21%	52,123 $354,000
Q4 2019 Jan 27, 2020	BUY	$9.77 - $15.66 $287,238 - $460,404	29,400 Added 205.26%	43,723 $651,000
Q3 2019 Oct 31, 2019	SELL	$9.59 - $12.0 $17,338 - $21,696	-1,808 Reduced 11.21%	14,323 $147,000
Q2 2019 Aug 15, 2019	BUY	$9.54 - $14.96 $58,489 - $91,719	6,131 Added 61.31%	16,131 $171,000
Q3 2017 Nov 15, 2017	BUY	$7.7 - $11.55 $77,000 - $115,500	10,000	10,000 $110,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account